The purpose of this study was to determine if patients with advanced HIV infection exhibit increased rates of leucine turnover and to determine dose effects of insulin on suppression of leucine turnover. We also wished to evaluate hepatic glucose production and re-examine peripheral insulin sensitivity in HIV infected adults.
Methods
Results from 9 males with advanced HIV disease (96-121% ideal body weight, NW-AIDS) and 3 males (80-88% ideal body weight, UW-AIDS) were compared to age and weight matched normal volunteers (NW-C and UW-C). Each subject underwent basal leucine turnover studies followed by insulin dose response studies using a step-up hyperinsulinemic euglycemic clamp (insulin dose: 10, 20 and 120 mU/mβ/min) and the stable isotope [1-¹³C]leucine. Hepatic glucose production was measured using the stable isotope d-6,6,H2-glucose. Resting energy expenditure (REE) was measured by indirect calorimetry and a 24-hour food recall was obtained. Viral load, Karnofsky score, and CD4 counts were measured in AIDS subjects.
Results
All subjects with AIDS had higher rates of leucine appearance (leucine Ra) than controls. Although both AIDS and Controls demonstrated suppression of leucine Ra with insulin, suppression was less in AIDS subjects. There was a strong relationship between leucine Ra and viral load (r = 0.87, P = 0.02). The AIDS subjects exhibited peripheral insulin resistance when compared to controls.
Conclusions
Our results suggest that patients with HIV have both peripheral insulin resistance and resistance to the anticatabolic effects of insulin.
KotlerD, WangJ, PiersonR.Body composition studies in patients with the aquired immunodeficiency syndrome. Am J Clin Nutr1985;42:1255–65.
2.
HellersteinMK, KahnJ, MudieH, ViteriF.Current approach to the treatment of human immunodeficiency virus-associated weight loss: pathophysiologic considerations and emerging management strategies. Semin Oncol1990;17:17–33.
3.
ChlebowskiRT. Significance of altered nutritional status in acquired immunodeficiency syndrome (AIDS). Nutr Cancer1985;12:85–91.
4.
KotlerDP, TierneyAR, WangJ, PiersonRN. Magnitude of bodycell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr1989;50:444–7.
5.
KotlerDP, WangJ, PiersonRN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr1985:42:1255–65.
6.
SteinTP, NutinskyC, CondoluciD, SchluterMD, LeskiwMJ. Protein and energy substrate metabolism in AIDS patients. Metabolism1990;39:876–81.
7.
SelbergO, SuttmannU, MelzerA, DeicherH, MullerMJ, HenkelE, McMillanDC. Effect of increased protein intake and nutritional status on whole-body protein metabolism of AIDS patients with weight loss. Metabolism1995;44:1159–65.
8.
MacallanDC, McNurlanMA, MilneE, CalderAG, GarlickPJ, GriffinGE. Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection. Am J Clin Nutr1995;61:818–26.
9.
ZhangX, KunkelKR, JahoorF, WolfeRR. Role of basal insulin in the regulation of protein kinetics and energy metabolism in septic patients. J Parenteral Enteral Nutr1991;15:394–99.
10.
JahoorF, ShangrawRE, MiyoshiH, WallfishH, HerndonDN, WolfeRR. Role of insulin and glucose oxidation in mediating the protein catabolism of burns and sepsis. Am J Physiol1989;257:E323–31.
11.
HardinDS, LeBlancA, LukenbaughS, ParaL, SeilheimerDK. Increased rates of proteolysis associated with insulin resistance in cystic fibrosis. Pediatr1998;101:948–56.
12.
HommesMJT, RomijinJA, EndertE, SchattenkerkJK, SauerweinHP. Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism1991;40:651–6.
MatthewsDE, SchwarzHP, YangRD, MotilKJ, YoungVR, BierDM. Relationship of plasma leucine and a-ketoisocaproate during a L-[1-¹³C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism1982;31(11):1105–12.
16.
MatthewsDE, MotilKJ, RohrbaughDK, BurkeJF, YoungVR, BierDM. Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-¹³C]leucine. Am J Physiol1980;238:E473–9.
17.
FinegoodDT, BergmanRN, VranicM.Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Diabetes1987;36:914–24.
18.
DeFronzoRA, JacotE, JequierE, MaederE, FellerJP. The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes1981;30:1000–7.
19.
FukagawaNK, MinakerKL, RoweJW, GoodmanMN, MatthewsDE, BierDM, YoungVR. Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J Clin Invest1985;76:2306–11.
20.
PetridesAS, GroopLC, RielyCA, DeFronzoRA. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis. J Clin Invest1991;88:561–70.
21.
JensenMD, KanaleyJA, RoustLR, O'BrienPC, BraunJS, DunnWL, WahnerHW. Assessment of body composition with use of dualenergy X-ray absorptiometry: Evaluation and comparison with other methods. Mayo Clin Proc1993;68:867–73.
22.
WeirJBD. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol1949;109:1–9.
23.
HarrisJA, BenedictFG. A biometric study of basal metabolism in man. Anonymous Carnegie Institute of Washington, Washington DC, 1919.
24.
KarnofskyDA, AbelmannWH, CraverLF, BurchenalJH. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer1948;1:634–56.
25.
SpachDH, HootonTM, eds. The HIV manual. Oxford, NY, Oxford University Press, 1996.
26.
MorganCR, LazaroA.Immunoassay of insulin: two antibody system. Plasma insulin levels in normal subdiabetic and diabetic rats. Diabetes1963;12:115–8.
27.
McNurlanMA, GarlickPJ. Influence of nutrient intake on protein turnover. Diabetes Metab Rev1989;5:165–89.
28.
RennieMJ, EdwardsRHT, HallidayD, MatthewsEE, WolmanSL, MillwardDJ. Muscle protein synthesis measured by stable isotope techniques in man: the effects of feeding and fasting. Clin Sci1982;63:519–23.
29.
McNurlanMA., EssenP, ThorellA, CalderAG, AndersonSE, LjungqvistO, SandgrenA, GrantI, TjaderI, BallmerPE, WernermanJ, GarlickPJ. Response of protein synthesis in human skeletal muscle to insulin: an investigation with L-[βH5]phenylalanine. Am J Physiol1994;267:E102–8.
30.
ShangrawRE, JahoorF, MiyoshiH, NeffWA, StuartCA, HerndonDN, WolfeRR. Differentiation between septic and postburn insulin resistance. Metabolism1989;38(10):983–9.
31.
YarasheskiKE, ZachwiejaJG, CrowleyJ, HorganMM, PowderlyWG. Increase plasma Gln and Leu Ra and inappropriately low muscle protein synthesis rate in AIDS wasting. Am J Physiol1999;38:E577–83.
32.
Yki-JarvinenH, SammalkorpiK, KoivistoVA. Severity, duration and mechanisms of insulin resistance during acute infections. J Clin Endocrinol Metab1989;69:317–23.
33.
BeaufrereB, HorberFF, SchwenkWF, MarshHM, MatthewsD, GerichJE, HaymondMW. Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. Am J Physiol1989;257 (20):E712–21.
34.
LortholaryO, ChristeffN, CasassusP, ThobieN, VeyssierP, TrogoffB, TorriO, BraunerM, NunezEA, GuillevinL.Hypothalamopituitary-adrenal function in human immunodeficiency virus-infected men. J Clin Endocrinol Metab1996;81:791–6.
35.
CollinsJR, CroffordOB. Glucose intolerance and insulin resistance in patients with liver disease. Arch Intern Med1969;124:142–8.
36.
HardinDS, LeBlancA, LukenbaughS, SeilheimerDK. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr1997;6:948–56.
37.
GarveyWT, MaianuL, HuecksteadtTP, BirnbaumMJ, MolinaJM, CiaraldiTP. Pretranslation suppression of a glucose transporter protein cause insulin resistance in adipocytes from patients with noninsulin dependent diabetes mellitus and obesity. J Clin Invest1991;87:1072–81.
38.
GarveyWT, KoltermanOG. Correlation of in vivo and in vitro actions of insulin in obesity and noninsulin-dependent diabetes mellitus: role of the glucose transport system. Diab Met Rev1988;4:543–69.
39.
WalliR, HerfortO, MichlGM, DemantT, JagerH, DieterleC, BognerJR, LandgrafR, GoebelFD. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS1998;12:F167–73.
40.
KienCL, HorswillCA, ZipfWB, McCoyKS, O'DorisioT.Elevated hepatic glucose production in children with cystic fibrosis. Pediatr Res1995;37:600–5.
41.
HardinDS, LeBlancA, ParaL, SeilheimerDK. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes1999. In press.
LanngS, ThorsteinssonB, RoderME, NerupJ, KochC.Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol1994;41:217–23.
44.
HardinDS, LukenbaughS, SeilheimerD.Cystic fibrosis is associated with insulin resistance which negatively impacts nutritional and clinical status. Pediatr Pulmonol1995;288(12 Suppl):385.
45.
FloresEA, BistrianBR, PomposelliJJ, DinarelloCA, BlackburnCL, IstfanNW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat: a synergistic effect with interleukin. J Clin Invest1989;83:1614–22.
46.
TheaDM, PoratR, NagimbiK, BanngiM, St. LouisME, KaplanG, DinarelloCA, KeuschGT. Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann Intern Med1996;124:757–62.
47.
TeramotoS, MatsuseT, OuchiY.Increased production of TNF-alpha may play a role in osteoporosis in cystic fibrosis patients. Chest1997;122:574–5.
48.
AnkerSD, ClarkAL, KempM, SalsburyC, TeixeiraMM, HellewellPG, CoatsAJS. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardio1997;30:997–1001.
49.
Lopes-VirellaMF, VirellaG.Modified lipoproteins, cytokines and macrovascular disease in noninsulin-dependent diabetes mellitus. Ann Med1996;28:347–54.
50.
RabinovitchA, Suarez-PinzonWL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol1998;55:1139–49.
51.
SakuraiY, ZhangXJ, WolfeRR. TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. Am J Physiol1996;270(33):E864–72.
52.
OfeiF, HurelS, NewkirkJ, SopwithM, TaylorR.Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes1996;45:881–5.
53.
HolecekM, SpronglL, SkopecF, AndrysC, PeckaM.Leucine metabolism in TNF-alpha and endotoxin treated rats: contribution of hepatic tissue. Am J Physiol1997;273:E1052–8.
54.
MacallanDC, NobleC, BaldwinC, JebbSA, PrenticeAM, CowardA, SawyerMB, McManusTJ, GriffinGE. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med1995;333:83–8.
55.
GrunfeldC, FeingoldKR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med1992;327:329–37.
56.
SmithCJ, NelsonRG, HardySA, ManahanEM, BennettPH, KnowlerWC. Survey of the diet of Pima indians using quantitative food frequency assessment and 24-hour recall. Diabetic renal disease study. J Am Diet Assoc1996;96:778–84.
57.
CrawfordPB, ObarzanekE, MorrisonJ, SabryZI. Comparative advantage of 3-day food records over 24-hour recall and 5-day food frequency validated by observation of 9-and 10-year old girls. J Am Diet Assoc1994;94:626–30.
58.
Beer-borstS, AmadoR.Validation of a self-administered 24-hour recall questionnaire used in a large-scale dietary survey. Zeitschrift fur Ernahrungswissenschaft1995;34:183–9.
59.
RiveraS, BriggsW, QianD, SattlerFR. Levels of HIV RNA are quantitatively related to prior weight loss in HIV-associated wasting. J Acquir Immune Defic Syndr1998;17:411–8.
